Exelixis (EXEL) EBITDA (2010 - 2026)

Exelixis' EBITDA history runs 17 years deep, the most recent figure standing at $251.3 million for Q2 2026.

• In Q2 2026, EBITDA rose 34.51% year-over-year to $251.3 million; the TTM figure through Apr 2026 stood at $936.7 million (up 22.92% YoY), while the FY2026 annual figure was $872.2 million, up 44.26% from the prior year.
• EBITDA was $251.3 million for Q2 2026 at Exelixis, up from $235.2 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $275.9 million in Q2 2024 to a low of -$48.1 million in Q4 2022.
• Historically, EBITDA has averaged $123.6 million across 5 years, with a median of $83.7 million in 2022.
• Biggest YoY gain for EBITDA was 1906.88% in 2022; the steepest drop was 140.74% in 2022.
• A 5-year view of EBITDA shows it stood at -$48.1 million in 2022, then soared by 270.12% to $81.8 million in 2023, then surged by 66.38% to $136.1 million in 2024, then soared by 73.83% to $236.5 million in 2025, then increased by 6.26% to $251.3 million in 2026.
• The last three EBITDA figures came in at $251.3 million (Q2 2026), $235.2 million (Q1 2026), and $236.5 million (Q4 2025), per Business Quant data.